JAK ANTAGONISTS AND IL-6 INHIBITORS FOR MANAGEMENT OF SARS-COV-2 INFECTION: A SYSTEMIC REVIEW AND NETWORK META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

Detalles Bibliográficos
Autores principales: KHANAM, RUKHSAAR, BHAGAVAN, MONICA, SHAH, AASHKA, NAIK, ANANT
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American College of Chest Physicians. Published by Elsevier Inc. 2022
Materias:
Chest Infection
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548709/
http://dx.doi.org/10.1016/j.chest.2022.08.463
_version_ 1784805492123500544
author KHANAM, RUKHSAAR
BHAGAVAN, MONICA
SHAH, AASHKA
NAIK, ANANT
author_facet KHANAM, RUKHSAAR
BHAGAVAN, MONICA
SHAH, AASHKA
NAIK, ANANT
author_sort KHANAM, RUKHSAAR
collection PubMed
description
format Online
Article
Text
id pubmed-9548709
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American College of Chest Physicians. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-95487092022-10-11 JAK ANTAGONISTS AND IL-6 INHIBITORS FOR MANAGEMENT OF SARS-COV-2 INFECTION: A SYSTEMIC REVIEW AND NETWORK META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS KHANAM, RUKHSAAR BHAGAVAN, MONICA SHAH, AASHKA NAIK, ANANT Chest Chest Infection American College of Chest Physicians. Published by Elsevier Inc. 2022-10 2022-10-10 /pmc/articles/PMC9548709/ http://dx.doi.org/10.1016/j.chest.2022.08.463 Text en Copyright © 2022 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Chest Infection
KHANAM, RUKHSAAR
BHAGAVAN, MONICA
SHAH, AASHKA
NAIK, ANANT
JAK ANTAGONISTS AND IL-6 INHIBITORS FOR MANAGEMENT OF SARS-COV-2 INFECTION: A SYSTEMIC REVIEW AND NETWORK META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
title JAK ANTAGONISTS AND IL-6 INHIBITORS FOR MANAGEMENT OF SARS-COV-2 INFECTION: A SYSTEMIC REVIEW AND NETWORK META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
title_full JAK ANTAGONISTS AND IL-6 INHIBITORS FOR MANAGEMENT OF SARS-COV-2 INFECTION: A SYSTEMIC REVIEW AND NETWORK META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
title_fullStr JAK ANTAGONISTS AND IL-6 INHIBITORS FOR MANAGEMENT OF SARS-COV-2 INFECTION: A SYSTEMIC REVIEW AND NETWORK META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
title_full_unstemmed JAK ANTAGONISTS AND IL-6 INHIBITORS FOR MANAGEMENT OF SARS-COV-2 INFECTION: A SYSTEMIC REVIEW AND NETWORK META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
title_short JAK ANTAGONISTS AND IL-6 INHIBITORS FOR MANAGEMENT OF SARS-COV-2 INFECTION: A SYSTEMIC REVIEW AND NETWORK META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
title_sort jak antagonists and il-6 inhibitors for management of sars-cov-2 infection: a systemic review and network meta-analysis of randomized controlled trials
topic Chest Infection
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548709/
http://dx.doi.org/10.1016/j.chest.2022.08.463
work_keys_str_mv AT khanamrukhsaar jakantagonistsandil6inhibitorsformanagementofsarscov2infectionasystemicreviewandnetworkmetaanalysisofrandomizedcontrolledtrials
AT bhagavanmonica jakantagonistsandil6inhibitorsformanagementofsarscov2infectionasystemicreviewandnetworkmetaanalysisofrandomizedcontrolledtrials
AT shahaashka jakantagonistsandil6inhibitorsformanagementofsarscov2infectionasystemicreviewandnetworkmetaanalysisofrandomizedcontrolledtrials
AT naikanant jakantagonistsandil6inhibitorsformanagementofsarscov2infectionasystemicreviewandnetworkmetaanalysisofrandomizedcontrolledtrials

Ejemplares similares